Clinical Trials in Austin

Showing 2601-2620 of 13,060 trials

Adaptation of SFA for HRW

NCT07149155

The aim of this study is to pilot and test the feasibility, acceptability, and effectiveness of a Stress First Aid (SFA) intervention adapted for Harm Reduction Workers (HRWs) serving Persons Who Use Drugs. The intervention consists of a training and learning collaboratives used to reinforce the SFA principles

Occupational Health

University of Texas at Austin35 participantsStarted Sep 2024

Austin, Texas, United States

Active Not RecruitingPhase 2/3< 1 mile

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

NCT05502341

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus current therapy (Phase 2) and BIC/LEN fixed-dose combination (FDC) versus current therapy (Phase 3) in people living with HIV (PWH).

HIV-1-infection

Gilead Sciences689 participantsStarted Aug 2022

Berkeley, California, United States • Beverly Hills, California, United States • Los Angeles, California, United States +91 more locations

Adaptation of SFA for HRW

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Find Trials by Condition in Austin

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

The Periviable GOALS Decision Support Tool

A Study of Inhaled AZD8630 in Adolescents With Asthma

A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Intent of Surgery for IPMN

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Prospective Clinical Assessment Study in Children With Hypochondroplasia

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies